Quantitation and Localization of Matrix Metalloproteinases and Their Inhibitors in Human Carotid Endarterectomy Tissues

Background—Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) play a central role in arterial wall remodeling, affecting stability of fibrous caps covering atherosclerotic plaques. The objective of this study was to determine the spatial distribution of TIMP mass and MMP mass and activity of carotid endarterectomy (CEA) tissues and relate it to the distribution of atherosclerotic lesions. Methods and Results—Fresh CEA tissues were imaged by multicontrast MRI to generate 3D reconstructions. Tissue segments were cut transversely from the common, bifurcation, internal, and external regions. Segments were subjected to total protein extractions and analyzed by ELISA for MMP-2 and -9 and TIMP-1 and -2 mass and by zymography for gelatinase activity. Segments at or near the bifurcation with highly calcified lesions contained higher MMP levels and activity than segments distant from the bifurcation; highly fibrotic or necrotic plaque contained lower MMP levels and activity and higher TIMP levels. Fatty streak, fibroatheroma with hemorrhage and calcification, and fully occluded lesions were enriched in MMP-2, MMP-9, and TIMP-1 and TIMP-2, respectively. Conclusion—The spatial distribution of MMPs and TIMPs in carotid atherosclerotic lesions is highly heterogeneous, reflecting lesion location, size, and composition. This study provides the first semi-quantitative maps of differential distribution of MMPs and TIMPs over atherosclerotic plaques.

[1]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[2]  A. Sterpetti,et al.  Metalloproteinases and their inhibitors are markers of plaque instability. , 2005, Surgery.

[3]  Stefan Agewall,et al.  Matrix metalloproteinases and cardiovascular disease. , 2006, European heart journal.

[4]  V. Fuster,et al.  Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions: Two Years’ Follow-Up by High-Resolution Noninvasive Magnetic Resonance Imaging , 2002, Circulation.

[5]  William Insull,et al.  Bilateral Symmetry of Human Carotid Artery Atherosclerosis , 2002, Stroke.

[6]  Christof Karmonik,et al.  Tracking regression and progression of atherosclerosis in human carotid arteries using high-resolution magnetic resonance imaging. , 2004, Magnetic resonance imaging.

[7]  Y. Tomino,et al.  Increased mRNA expression of metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin A nephropathy. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  J. Stone,et al.  Metalloproteinase-2 and -9 in Giant Cell Arteritis: Involvement in Vascular Remodeling , 2005, Circulation.

[9]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[10]  D. Corbett,et al.  Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases , 2003, Annals of neurology.

[11]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[12]  J. Hoff,et al.  Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors , 2005 .

[13]  R. Williamson,et al.  The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. , 1991, Biochemistry.

[14]  P. Soloway,et al.  TIMP-2 Is Required for Efficient Activation of proMMP-2 in Vivo * , 2000, The Journal of Biological Chemistry.

[15]  P. Richardson,et al.  Collagen types I and III, collagen content, GAGs and mechanical strength of human atherosclerotic plaque caps: span-wise variations. , 1992, Atherosclerosis.

[16]  Renu Virmani,et al.  Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.

[17]  H. Birkedal‐Hansen,et al.  Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[18]  P. Giral,et al.  Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia. , 2003, Atherosclerosis.

[19]  J. W. Von den Hoff,et al.  Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. , 2005, BioTechniques.

[20]  Zhenlin Ju,et al.  Application of protein lysate microarrays to molecular marker verification and quantification , 2005, Proteome Science.

[21]  Seth A Marvel,et al.  Quantification of calcification in atherosclerotic lesions. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[22]  G. Murphy.  Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitor. , 1989, Matrix (Stuttgart, Germany). Supplement.

[23]  Minh N. H. Nguyen,et al.  Activated Protein C Directly Activates Human Endothelial Gelatinase A* , 2000, The Journal of Biological Chemistry.

[24]  T. Wight,et al.  The extracellular matrix and atherosclerosis , 1995, Current opinion in lipidology.

[25]  K. Brew,et al.  Tissue inhibitors of metalloproteinases: evolution, structure and function. , 2000, Biochimica et biophysica acta.

[26]  H. Nagase,et al.  Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) is induced in rabbit articular chondrocytes by cotreatment with interleukin 1 beta and a protein kinase C activator. , 1992, Experimental cell research.

[27]  Z. Galis,et al.  Matrix Metalloproteinase-2 and −9 Differentially Regulate Smooth Muscle Cell Migration and Cell-Mediated Collagen Organization , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[28]  Chun Yuan,et al.  Presence of Intraplaque Hemorrhage Stimulates Progression of Carotid Atherosclerotic Plaques: A High-Resolution Magnetic Resonance Imaging Study , 2005, Circulation.

[29]  L. Kotra,et al.  Matrix metalloproteinases: structures, evolution, and diversification , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  F. Bernini,et al.  HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[31]  A. Darzi,et al.  Relationship of Matrix Metalloproteinases and Macrophages to Embolization during Endoluminal Carotid Interventions , 2004, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[32]  G. Schneider,et al.  Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. , 1999, Science.